Studies show it affects only about 0.5% of every 1,000 people taking GLP-1 medications like Ozempic and Wegovy
In Eli Lilly's pivotal Phase 3 ATTAIN clinical trialsthe studies that led to FDA approvalparticipants taking orforglipron achieved average body weight reductions of approximately 7.9% to 8.7% over 36 to 40 weeks, depending on the dosing
2 By moving to proactive monitorization, the FDA aims to ensure that all promotional content represents a fair balance of risks and benefits, as required by the Federal Food, Drug, and Cosmetic Act
According to Yucca Health's safety information pages, the most common side effects include: Gastrointestinal Effects: Nausea (most common, especially early on) Diarrhea Constipation Vomiting Indigestion and abdominal discomfort Feeling full quickly after eating Other Common Effects: Headache Fatigue Dizziness Managing Side Effects: Most patients find that nausea and gastrointestinal symptoms improve as the body adjusts to the medication
El ecosistema integral de VivaWell combina tecnologa predictiva, acompaamiento mdico constante y acceso inmediato a especialistas